Harshman, L. C., Chen, Y., Liu, G., Carducci, M. A., Jarrard, D., Dreicer, R., . . . Sweeney, C. J. (2018). Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J Clin Oncol.
シカゴスタイル引用形Harshman, Lauren C., et al. "Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel." J Clin Oncol 2018.
MLA引用形式Harshman, Lauren C., et al. "Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel." J Clin Oncol 2018.
警告: この引用は必ずしも正確ではありません.